Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
01:34:07 EDT Tue 07 May 2024
Enter Symbol
or Name
USA
CA



News for U:INM from 2023-05-08 to 2024-05-07 - 30 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-18 08:01U:INMNews ReleaseInMed Appoints Dr. David G. Morgan, PhD, a Leading Alzheimer's Expert, to the Company's Scientific Advisory Board
2024-04-16 08:02U:INMNews ReleaseInMed Provides Update on INM-089 in the Treatment of Dry Age-Related Macular Degeneration
2024-04-04 08:01U:INMNews ReleaseInMed's INM-901 Demonstrates Favorable Pharmacological and Behavioral Effects in In Vivo Preclinical Alzheimer's Disease Studies
2024-03-20 08:32U:INMNews ReleaseInMed Granted 180-Day Extension to Achieve Nasdaq Minimum Bid Compliance
2024-02-13 18:10U:INMSEDAR Interim Financial StatementsSEDAR Interim MD & A
2024-02-13 17:42U:INMNews ReleaseInMed Reports Second Fiscal Quarter 2024 Financial Results and Provides Business Update
2024-02-09 08:01U:INMNews ReleaseInMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
2024-01-18 16:42U:INMNews ReleaseInMed to Discuss Its Pharmaceutical Pipeline and 2024 Strategic Priorities in Fireside Chat with Water Tower Research on January 25, 2024 at 1pm ET
2024-01-16 08:02U:INMNews ReleaseInMed Pharmaceuticals Provides Business Update and Milestones for 2024
2023-12-19 18:04U:INMNews ReleaseInMed Announces Results of 2023 Annual General Meeting
2023-11-29 08:01U:INMNews ReleaseInMed Expands its Pharmaceutical Pipeline with INM-089 targeting the treatment of Age-Related Macular Degeneration
2023-11-14 08:40U:INMSEDAR Interim MD & ASEDAR Interim Financial Statements
2023-11-14 08:06U:INMNews ReleaseInMed Reports First Quarter Fiscal 2024 Financial Results and Provides Business Update
2023-11-02 08:01U:INMNews ReleaseInMed Announces Presentation of INM-755 Phase 2 Clinical Study Results at 12th World Congress on Itch (WCI) 2023
2023-10-26 19:16U:INMNews ReleaseInMed Pharmaceuticals Announces the Closing of $5.2 Million Private Placement and Preferred Investment Option Exercise Priced At-the-Market Under Nasdaq Rules
2023-10-24 16:39U:INMNews ReleaseInMed Pharmaceuticals Announces $5.2 Million Private Placement and Preferred Investment Option Exercise Priced At-the-Market under Nasdaq Rules
2023-10-24 07:31U:INMNews ReleaseInMed Pharmaceuticals Inc.'s INM-901 Demonstrates Unique Pharmacological Effects in Alzheimer's Disease in Preclinical Proof-of-Concept Studies
2023-09-29 13:22U:INMNews ReleaseInMed Pharmaceuticals Reports Full Year Fiscal 2023 Financial Results and Provides Business Update
2023-09-29 13:15U:INMSEDAR Annual ReportSEDAR Annual Report
2023-09-29 13:10U:INMSEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2023-09-22 18:16U:INMNews ReleaseInMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance
2023-09-07 08:31U:INMNews ReleaseInMed to Present at H.C. Wainwright 25th Annual Global Investment Conference
2023-07-21 07:31U:INMNews ReleaseInMed to Participate in Fireside Chat with Water Tower Research on July 25, 2023 at 2pm ET
2023-07-20 07:31U:INMNews ReleaseInMed Provides Update on BayMedica Rare Cannabinoid Business
2023-06-22 07:31U:INMNews ReleaseInMed Pharmaceuticals Inc. Announces Results from a Phase 2 Clinical Trial in Epidermolysis Bullosa
2023-06-01 07:31U:INMNews ReleaseInMed's Neurodegenerative Disease Study Presented at Canadian Neuroscience Meeting
2023-05-24 18:52U:INMNews ReleaseInMed to Participate in Upcoming Virtual Investor Events
2023-05-18 17:01U:INMNews ReleaseInMed to Participate in Fireside Chat with Water Tower Research on May 23, 2023 at 1pm ET
2023-05-15 14:59U:INMSEDAR MD & ASEDAR Interim Financial Statements
2023-05-15 12:34U:INMNews ReleaseInMed Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Update